WuXi News
WuXi NextCODE in Bloomberg on Ending a 30-year Diagnostic Odyssey in 3 Weeks


WuXi NextCODE Featured in Nature as the Innovative Engine of Population-scale Precision Medicine at Genomics England and Beyond 
  
WuXi Receives 2015 Open-Access R&D Technology Leadership Award from Frost & Sullivan
  
WuXi NextCODE and Fudan Children's Hospital Partner to Lead Whole Genome Diagnostics for Rare Diseases in China 

WuXi's STA Subsidiary Receives First Approval from Japanese Regulatory Authorities


WuXi to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm


WuXi and TruTag Technology Advances Edible On-Dose Authentication Solution for Pharmaceuticals 


Perspectives
An Interview with Dr. Steve Yang, EVP and COO of WuXi AppTec and the New Head of IDSU


Meet WuXi's Israel Partner: An Interview with Ran Nussbaum, Co-Founder and Managing Partner of Pontifax

 
In This Issue:
 
Industry Beats






 
Penumbra, Inc. Announces Pricing of Initial Public Offering(Source: Penumbra)



Versant Ventures Broadens Geographic Footprint with Highline Therapeutics (Source: Versant Ventures)
FDA Approvals & Designations


 

Upcoming Events
September 30, 2015
Online

October 13, 2015
CLSA, South San Francisco

October 27, 2015
California Academy of Sciences

October 27-28, 2015
Santa Clara Convention Center

November 3-4, 2015
Hyatt Regency San Francisco Airport
 
WuXi AppTec
953 Indiana Street
San Francisco, CA 94107

 
Follow us on TwitterView our profile on LinkedIn